AbbVie announced that the FDA has rejected its application for ABBV-951 to control motor fluctuations in advanced Parkinson’s disease patients. Foscarbidopa and foslevodopa, the prodrugs for the widely used carbidopa and levodopa, respectively, are already included in AbbVie’s Duopa as part of the treatment. Prodrugs are versions of drugs that work once they are in […]
Continue Reading
After Equatorial Guinea confirmed its first Marburg virus disease outbreak on February 13, 2023, the health officials around the world are rushing to test whether experimental vaccines can protect against a deadly disease. The virus has similarities to Ebola in its hemorrhagic fever symptoms. It has a casualty pace of up to 88%. Yesterday, an […]
Continue Reading
On Monday, February 13, 2023, Natco Pharma announced that it had submitted a new application to the US health regulator for marketing authorization of the generic version of Olaparib tablets, which are used to treat some types of ovarian, breast, pancreatic, and prostate cancer. The generic version of AstraZeneca’s Olaparib tablets in strengths of 100mg […]
Continue Reading
On January 11, 2023, India had recorded 171 new cases of COVID-19 infection, bringing the total number of active cases to 2,342, according to data on the Health Ministry’s website. The rate of case fatalities was approximately 1.19 percent. The weekly positivity rate was 0.11 percent, while the daily positivity rate was 0.09 percent. According […]
Continue Reading
According to the Centers for Disease Control and Prevention (CDC), multiple respiratory viruses are co-circulating with influenza in the United States, and the CDC has urged people to get flu shots and COVID-19 booster shots to avoid serious illness. According to the CDC, seasonal flu activity is high across the United States, with at least […]
Continue Reading
The US Food and Drug Administration (FDA) has approved KRAZATI, a targeted treatment for adult patients with KRAS metastatic non-small cell lung cancer (NSCLC), developed by Mirati Therapeutics Inc. Based on the objective response rate (ORR) and duration of response (DOR), the treatment receives expedited approval. The description and verification of a clinical benefit in […]
Continue Reading
The US Centers for Disease Control and Prevention (CDC) are investigating the cause of the listeria outbreak across six states in the United States. The US CDC has issued an advisory for the people who consume Deli meat, including lunch meats, cold cuts, and hot dogs. The older individuals above 65 years, pregnant women, and […]
Continue Reading
According to a new report, cases of mouth cancer in United Kingdom increased by more than one-third in last decade and has reached a record high. The number of mouth cancer cases in UK has doubled within the last generation and include common causes such as drinking and smoking with other lifestyle factors. 8,864 people […]
Continue Reading
The US Food and Drug Administration (FDA) of the United States has approved the on-body infusor ‘Furoscix’ for congestive heart failure developed by scpharmaceuticals. With this approval, Furoscix becomes the first self-administered, and subcutaneous loop diuretic for people with worsening heart failure. This infusor delivers generic furosemide that relieves fluid retention and swelling, which causes […]
Continue Reading
The UK Health Security Agency announced that people at high risk of contracting monkeypox disease will be offered second doses of the vaccine. UKSHA said sexual health clinics will continue to prioritise offering first doses of the monkeypox vaccine to those at high risk. Some clinics will offer a second dose to the eligible people, […]
Continue Reading